Author/Creator: Felizzi, Federico - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Felizzi, Federico

1. Cost-effectiveness of atezolizumab versus docetaxel and nivolumab in the treatment of non-small cell lung cancer as a second line in France. (3rd May 2020)

Authors:: Marine, Sivignon; Stéphane, Roze; Nicolas, Plommet; Felizzi, Federico; Paracha, Noman; Benjamin, Mazaleyrat; Perol, Maurice
Journal:: Journal of medical economics
Issue:: Volume 23:Number 5(2020)
Page Start:: 464
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Cost-effectiveness of second-line atezolizumab in Canada for advanced non-small cell lung cancer (NSCLC). (3rd July 2019)

Authors:: Ondhia, Umang; Conter, H. J.; Owen, Scott; Zhou, Anna; Nam, Julian; Singh, Sumeet; Abdulla, Ahmed; Chu, Paula; Felizzi, Federico; Paracha, Noman; Sangha, Randeep
Journal:: Journal of medical economics
Issue:: Volume 22:Number 7(2019)
Page Start:: 625
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Semiparametric estimation of the cure fraction in population‐based cancer survival analysis. (28th July 2020)

Authors:: Gu, Ennan; Zhang, Jiajia; Lu, Wenbin; Wang, Lianming; Felizzi, Federico
Journal:: Statistics in medicine
Issue:: Volume 39:Number 26(2020)
Page Start:: 3787
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗